Patriot Financial Group Insurance Agency, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 238 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Patriot Financial Group Insurance Agency, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2022$8,000
-27.3%
127
-18.6%
0.00%0.0%
Q1 2022$11,000
-21.4%
156
-6.0%
0.00%0.0%
Q4 2021$14,000
-6.7%
166
+1.2%
0.00%
-33.3%
Q3 2021$15,000
+15.4%
164
+20.6%
0.00%
+50.0%
Q2 2021$13,000
-13.3%
1360.0%0.00%
-33.3%
Q1 2021$15,000
-21.1%
1360.0%0.00%
-40.0%
Q4 2020$19,000
+72.7%
1360.0%0.01%
+25.0%
Q3 2020$11,0000.0%1360.0%0.00%0.0%
Q2 2020$11,000
+83.3%
136
-2.9%
0.00%
+33.3%
Q1 2020$6,0001400.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2021
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$5,084,0002.52%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,237,825$83,900,0001.18%
CAPITAL INTERNATIONAL LTD /CA/ 206,718$14,011,0000.91%
Cormorant Asset Management, LP 75,000$5,084,0000.74%
Capital International Sarl 107,450$7,283,0000.63%
Rock Springs Capital Management LP 159,750$10,828,0000.62%
Opus Point Partners Management, LLC 12,201$827,0000.61%
Hood River Capital Management LLC 109,629$7,431,0000.56%
Aureus Asset Management, LLC 50,740$2,927,0000.51%
ROCKEFELLER FINANCIAL SERVICES INC 374,663$25,395,0000.51%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders